Sunshine Biopharma, Inc.
Price Action
Technical Summary
DOWNTRENDSunshine Biopharma, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 1), showing significant lag compared to the market leaders. Earnings growth of 43% provides fundamental context to the price action. Investors should exercise caution due to high volatility (158% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.29 | -4.76% | BELOW |
| 50 SMA | $5.78 | -62.28% | BELOW |
| 100 SMA | $8.46 | -74.22% | BELOW |
| 150 SMA | $10.08 | -78.38% | BELOW |
| 200 SMA | $11.73 | -81.42% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SBFM in an uptrend right now?
SBFM has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is SBFM overbought or oversold?
SBFM's RSI (14) is 32. The stock is in neutral territory, neither overbought nor oversold.
Is SBFM outperforming the market?
SBFM has a Relative Strength (RS) Rating of 1 out of 99. SBFM is currently lagging the broader market.
Where is SBFM in its 52-week range?
SBFM is trading at $2.18, which is 9% of its 52-week high ($24.30) and 4% above its 52-week low ($1.22).
How volatile is SBFM?
SBFM has a Beta of 1.01 and 52-week volatility of 158%. It's more volatile than the S&P 500 - expect bigger swings.